Biotech Investors Playing It Safe
TheStreet.com's biotech specialist, Adam Feuerstein, gives the highlights from the BioCEO Conference and explains why biotech investors may want to stick with ETFs for a while.

Click here to watch the video.

Biotech Investors Playing It Safe
TheStreet.com's biotech specialist, Adam Feuerstein, gives the highlights from the BioCEO Conference and explains why biotech investors may want to stick with ETFs for a while.

Click here to watch the video.

looking for growth more long term than single play

From Barrons 4/16/07

"We like biotech a lot. We think biotech is a good way to play an M&A boom as large-cap pharmaceutical companies move to fill big holes in their product pipelines. There are relatively few companies within the biotech industry that have large enough market caps to make a difference. You can buy anything within the biotech industry above a billion dollars and it will likely be a takeover candidate sometime in the next year or two."

I think you have to have a toe in Bio-techs for the long run.

I believe one of these will be huge eventually

Cramer

bio